Biological effects of progestins in breast cancer

REFERENCES

• Longacre TA, Bartow SA. A correlative morpho-logic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986;10: 382–93
   PubMed Web of Science ®Google Scholar
• Topper YJ, Freeman CS. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 1980;60:1049–106
   PubMed Web of Science ®Google Scholar
• van Bogaert U. Effect of hormone on human mammary duct in vivo. Horm Metab Res 1978;10: 337–40
   PubMed Web of Science ®Google Scholar
• McManus MJ, Welsch CW. The effect ofestrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer 1984;54:1920–7
   PubMed Web of Science ®Google Scholar
• Laidlaw IJ, Clarke RB, Howell A, et al. The prolif-eration of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 1995;136: 164–71
   PubMed Web of Science ®Google Scholar
• Gompel A, Malet C, Spritzer P, et al. Progestin effect on cell proliferation and 17I3-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J Clin Endocrinol Metab 1986;63: 1174–80
   PubMed Web of Science ®Google Scholar
• Longman SM, Buehring GC. Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth. Cancer 1987;59:281–7
   Google Scholar
• Jones B, Russo J. Influence of steroid hormones on the growth fraction of human breast carcinomas. Am J Clin Pathol 1987;88:132–8
   PubMed Web of Science ®Google Scholar
• Botella J, Duranti E, Duc I, et al. Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T-47D human breast cancer cells. J Steroid Biochem Mol Biol 1994;50:41–7
   PubMed Web of Science ®Google Scholar
• Vignon F, Bardon S, Chalbos D, et al. Anti-estrogenic effect of R-5020, a synthetic progestin in human breast cancer cells in culture. J Clin Endocrinol Metab 1983;56:1124–30
   PubMed Web of Science ®Google Scholar
• Horwitz KB, Freidenberg GR. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T-47Dco human breast cancer cells by progestins: implication for endocrine therapies. Cancer Res 1985;45:167–73
   PubMed Web of Science ®Google Scholar
• Murphy LC, Dotzlaw H, AlkhalafM, et al. Mecha-nisms of growth inhibition by antiestrogens and progestins in human breast and endometrial cancer cells. J Steroid Biochem Mol Biol 1992;43:117–21
   PubMed Web of Science ®Google Scholar
• Musgrove EA, Lee CS, Sutherland RL. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of trans-forming growth factor alpha, epidermal growth factor receptor, c-fos and c-myc genes. Mol Cell Biol 1991;11:5032–43
   Google Scholar
• Jeng M-H, Parker CJ, Jordan VC. Estrogenic potential of progestins in oral contracteptives to stimulate human breast cancer cell proliferation. Cancer Res 1992;52:6539–46
   Google Scholar
• Kalkhoven E, Kwakkenbos-Isbriicker L, de Laat SW, et al. Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. Mol Cell Endocrinol 1994;102: 45–52
   PubMed Web of Science ®Google Scholar
• Papa V, Reese CC, Brunetti A, et al. Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells. Cancer Res 1990;50:7858–62
   PubMed Web of Science ®Google Scholar
• Hissom JR, Moore MR. Progestin effects on growth in the human breast cancer cell line T-47D — possible therapeutic implications. Biochem Biophys Res Commun 1987;145:706–11
   PubMed Web of Science ®Google Scholar
• Catherino WH, Jeng M-H, Jordan VC. Norgestrel and gestodene stimulate breast cancer cell growth through an estrogen receptor mediated mechanism. Br J Cancer 1993;67:945–52
   Google Scholar
• Schatz RW, Soto AM, Sonnenschein C. Effects of interaction between estradio1-1713 and pro-gesterone on the proliferation of cloned breast tumor cells (MCF-7 and T-47D). J Cell Physiol 1985;124: 386–90
   Google Scholar
• Markiewicz L, Hochberg RB, Gurpide E. Intrinsic estrogenicity of some progestagenic drugs .J Steroid Biochem Mol Biol 1992;41:53–8
   PubMed Web of Science ®Google Scholar
• Markiewicz L, Gurpide E. Estrogenic and progestagenic activities coexisting in steroidal drugs: quantitative evaluation by in vitro bioassays with human cells. J Steroid Biochem Mol Biol 1994; 48:89–94
   PubMed Web of Science ®Google Scholar
• Bo tella J, Po rthe-Nib elle J, Paris J, et al. Interaction of new 19-nor progesterone derivatives with progestagen, mineralocorticoid and glucocorticoid cytosolic receptors. J Pharmacol 1986;17: 699–706
   Google Scholar
• Catherino WH, Jordan VC. Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity. J Steroid Biochem Mol Biol 1995;55:239–46
   PubMed Web of Science ®Google Scholar
• Thuneke I, Schulte HM, Bamberger AM. Biphasic effect of medroxyprogesterone-acetate (MPA) treatment on proliferation and cyclin D1 gene transcription in T47D breast cancer cells. Breast Cancer Res Treat 2000;63: 243–8
   Google Scholar
• van der Berg B, Kalkhoven E, Isbriicker L, et al. Effects of pro gestins on the proliferation of oestro-gen-dependent human breast cancer cells under growth factor-defined conditions. J Steroid Biochem Mol Biol 1992;42:457–69
   PubMed Web of Science ®Google Scholar
• Hissom JR, Bowden RT, Moore MR. Effects of progestins, estrogens and antihormones on growth and lactate dehydrogenase in the human breast cancer cell line T-47D. Endocrinology 1989;125: 418–23
   Google Scholar
• Nardulli AM, Greene GL, O'Malley BW, et al. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 1988;122: 935–44
   Google Scholar
• Alexander IE, Shine J, Sutherland RL. Progestin regulation of estrogen receptor messenger RNA in human breast cancer cells. Mol Endocrinol 1990;4: 821–8
   Google Scholar
• Perez-Palacios G, Cerbon MA, Pasapera AM, et al. Mechanisms of hormonal and antihorrnonal action of contraceptive progestins at the molecular level. J Steroid Biochem Mol Biol 1992;41:479–85
   Google Scholar
• Read LD, Snider CE, Miller JS, et al. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol Endocrinol 1988;2: 263–71
   PubMedGoogle Scholar
• Goldfine ID, Papa V, Vignerie R, et al. Progestin regulation of insulin and insulin-like growth factor-I (IGF-I) receptors in cultured human breast cancer cells. Breast Cancer Res Treat 1992; 22:69–79
   PubMed Web of Science ®Google Scholar
• Papa V, Hartmann KKP, Rosenthal SM, et al. Progestins induce down-regulation of insulin-like growth factor (IGF-I) receptors in human breast cancer cells: potential auto crine role of IGF-II. Mol Endocrinol 1991;5:709–17
   PubMedGoogle Scholar
• Yee D. The insulin-like growth factor system as target in breast cancer. Breast Cancer Res Treat 1994;32:85–95
   PubMed Web of Science ®Google Scholar
• Alkhalaf M, Murphy LC. Regulation of c-jun and jun-B by in T-47D human breast cancer cells. Mol Endocrinol 1992;6:1625–33
   PubMedGoogle Scholar
• Wong MMSJ, Murphy LC. Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells. J Steroid Biochem Mol Biol 1991;39:39–44
   PubMed Web of Science ®Google Scholar
• Moore MR, Zhou J-L, Blankenship KA, et al. A sequence in the 5' flanking region confers progestin responsiveness on the human c-myc gene. J Steroid Biochem Mol Biol 1997;62: 243–52
   Google Scholar
• Hurd C, Khattree N, Alban P, et al. Hormonal regulation of the p53 tumor suppressor protein in T-47D human breast carcinoma cell line. J Biol Chem 1995;270:28507–10
   PubMed Web of Science ®Google Scholar
• Lipton A, Santner SJ, Santen RJ, et al. Aromatase activity in primary and metastatic human breast cancer. Cancer 1987;59:779–82
   PubMed Web of Science ®Google Scholar
• Perel E, Daniilescu D, Kharlip L, et al. Steroid modulation of aromatase activity in human cul-tured breast carcinoma cells. J Steroid Biochem Mol Biol 1988;29:393–9
   Web of Science ®Google Scholar
• Dao TL, Hayes C, Libby PR. Steroid sulfatase activities in human breast tumors. Proc Soc Exp Biol Med 1974;146:381–4
   PubMed Web of Science ®Google Scholar
• Pasqualini JR, Gelly C, Nguyen B-L, et al. Impor-tance of estrogen sulfates in breast cancer. J Steroid Biochem Mol Biol 1989;34:155–63
   Google Scholar
• Pasqualini JR., Gelly C, Lecerf F. Biological effects and morphological responses to estriol, estriol-3-sulfate, estrio1-17-sulfate and tamoxifen in a tamoxifen-resistant cell line (R-27) derived from MCF-7 human breast cancer cells. EurJ Cancer Clin Oncol 1986;22: 1495–501
   Google Scholar
• Santner SJ, Feil PD, Santen RJ. In situ estrogen pro-duction via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J Clin Endocrinol Metab 1984;59:29–33
   Google Scholar
• Pasqualini JR, Chetrite G, Blacker C, et al. Con-centrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer. J Clin Endocrinol Metab 1996;81:1460–4
   PubMed Web of Science ®Google Scholar
• Pasqualini JR., Ebert C, Chetrite G. Control of estradiol in human breast cancer. Effect of medrogestone on sulfatase, 173-hydroxysteroid dehydrogenase and sulfotransferases activities in human breast cancer cells. In Proceedings of the IV European Congress on Menopause. Paris: Editions ESKA, 1998:625–33
   Google Scholar
• Pasqualini JR., Varin C, Nguyen B-L. Effect of the progestagen R-5020 (promegestone) and of pro-gesterone on the uptake and on the transformation of estrone sulfate in the MCF-7 and T-47D human mammary cancer cells: correlation with progester-one receptor levels. Cancer Lett 1992;66: 55–60
   Google Scholar
• Chetrite G, Paris J, Botella J, et al. Effect of nomegestrol acetate on estrone-sulfatase and 173-hydroxysteroid dehydrogenase activities in human breast cancer cells. J Steroid Biochem Mol Biol 1996;58:525–31
   PubMed Web of Science ®Google Scholar
• Nguyen B-L, Ferme I, Chetrite G, et al. Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary can-cer cells. J Steroid Biochem Mol Biol 1993;46: 17–23
   Google Scholar
• Carlström K, Doberl A, Pousette A, et al. Inhibition of steroid sulfatase activity by danazol. Acta Obstet Gynecol Scand 1984;123(Suppl):107–11
   Google Scholar
• Evans TRJ, Rowlands MG, Jarman M, et al. Inhibition of estrone sulfatase enzyme in human placenta and human breast carcinoma. J Steroid Biochem Mol Biol 1991;39:493–9
   PubMed Web of Science ®Google Scholar
• Chetrite G, Varin C, Delalonde L, et al. Effect of promegestone, tamoxifen, 4-hydroxytamoxifen and ICI 164,384 on the o es tro ne sulphatase activity of human breast cancer cells. Anticancer Res 1993; 13:931–4
   PubMed Web of Science ®Google Scholar
• Pasqualini JR., Maloche C, Maroni M, et al. Effect of the progestagen promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells. Anticancer Res 1994; 14:1589–94
   PubMed Web of Science ®Google Scholar
• Andersson S, Moghrabi N. Physiology and molecular genetics of 17P-hydroxysteroid dehydrogenases. Steroids 1997;62:143–7
   PubMed Web of Science ®Google Scholar
• Adamski J, Jakob FJ. A guide to 1713-hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2001;171:1–4
   PubMed Web of Science ®Google Scholar
• Nguyen B-L, Chetrite G, Pasqualini JR. Trans-formation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol and promegestone (R-5020). Breast Cancer Res Treat 1995;34: 139–46
   Google Scholar
• Malet C, Vacca A, Kuttenn F, et al. 1713-Hydroxysteroid dehydrogenase (E2DH) activity in T47D cells. J Steroid Biochem Mol Biol 1991;39: 769–75
   PubMed Web of Science ®Google Scholar
• Adams EF, Coldham NG, James VHT. Steroidal regulation of o es tradio1-1713-dehydro genas e activ-ity of the human breast cancer cell line MCF-7. J Endocrinol 1988;118: 149–54
   Google Scholar
• Coldham NG, James VHT. A possible mechanism for increased breast cell proliferation by progestins through increased reductive 1713-hydroxysteroid dehydrogenase activity. IntJ Cancer 1990;45:174–8
   PubMed Web of Science ®Google Scholar
• Couture P, Theriault C, Simard J, et al. Androgen receptor-mediated stimulation of 173-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Endocrinology 1993;132:179–85
   PubMed Web of Science ®Google Scholar
• Poutanen M, Isomaa V, Kainulainen K, et al. Progestin induction of 17P-hydroxysteroid dehydrogenase enzyme protein in the T-47D human breast cancer cell line. Int J Cancer 1990; 46:897–901
   PubMed Web of Science ®Google Scholar
• Anderson E, Howell A. Oestrogen sulpho-transferases in malignant and normal human breast tissue. Endocr Re/at Cancer 1995;2:227–33
   Google Scholar
• Luu-The V, Bernier F, Dufort I. Steroid sulfotransferases. J Endocrinol 1996;150:587–97
   Google Scholar
• Chetrite G, Le Nestour E, Pasqualini JR. Estrogen sulfotransferase activities and its rrLRNA in various breast cancer cell lines. Effect of the progestin, promegestone (R-5020).J Steroid Biochem Mol Biol 1998;66: 295–302
   Google Scholar
• Chetrite GS, Ebert C, Wright F, et al. Control of sulfatase and sulfotransferase activities by medro-gestone in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines. J Steroid Biochem Mol Biol 1998;70:39–45
   Web of Science ®Google Scholar